Co-beneldopa (Benserazide/levodopa) Prescribing at THE RED HOUSE GROUP
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
339
Total Quantity
55.6K
NHS Cost
£3.8K
vs National Avg
+124.3%
THE RED HOUSE GROUP prescribed 339 items of Co-beneldopa (Benserazide/levodopa) over the last 12 months at a cost of £3,775 to the NHS. This is 124.3% above the national average prescribing rate. Co-beneldopa (Benserazide/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jun 2026
49
Jun 2026
25
Jun 2026
38
Jun 2026
26
Jun 2026
21
Jun 2026
28
Jun 2026
19
Jun 2026
23
Jun 2026
16
Jun 2026
40
Jun 2026
26
Jun 2026
28
Prescribing Details
| Total Items | 339 |
|---|---|
| Total Quantity | 55,600 |
| Total NHS Cost | £3,775 |
| Presentations | 10 different forms |
| vs National Average | +124.3% |
Co-beneldopa (Benserazide/levodopa) Prescribing Comparison
| This practice | 339 items |
|---|---|
| National average per practice | 151 items |
| Difference | +124.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.